共 50 条
Therapy of Aortic Valve Stenosis Using Next Generation Transcatheter Heart Valves
被引:0
|作者:
Schaefer, A.
[1
]
Conradi, L.
[1
]
Schaefer, U.
[2
]
机构:
[1] Univ Herzzentrum Hamburg, Klin & Poliklin Herz & Gefasschirurg, Martinistr 52, D-20253 Hamburg, Germany
[2] Univ Herzzentrum Hamburg, Klin Allgemeine & Intervent Kardiol, Hamburg, Germany
关键词:
aortic valve stenosis;
TAVI;
transcatheter heart valves;
D O I:
10.1055/s-0041-110767
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Transcatheter aortic valve implantation (TAVI) is an established therapy for aortic valve stenosis in the elderly and high-risk patients. Commercially available transcatheter heart valves (THV) like the CoreValve (R) (Medtronic, Inc., Minneapolis, MN, USA) and the Edwards SAPIEN (TM) (Edwards Lifesciences, Irvine, CA, USA) were utilized in several thousand procedures and pioneered transcatheter heart valve procedures in Europe. In the meantime different companies developed TAVI systems using various technologies, mainly triggered by obvious shortcomings of current devices. In the following an overview of selected next-generation TAVI devices is given.
引用
收藏
页码:52 / 58
页数:7
相关论文